Cyclooxygenase knockout mice: models for elucidating isoform-specific functions

R Langenbach1, C Loftin, C Lee

  • 1National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA. langenbach@niehs.nih.gov

Biochemical Pharmacology
|September 16, 1999
PubMed

Insights

Mice lacking cyclooxygenase-2 (COX-2) show more significant physiological effects than those lacking cyclooxygenase-1 (COX-1). This research explores COX-deficient mouse models to understand prostaglandin functions.

Area of Science:

  • Biochemistry
  • Genetics
  • Physiology

Background:

  • Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, produce prostaglandins involved in various physiological processes.
  • Understanding the distinct roles of COX-1 and COX-2 is crucial for targeted therapeutic development.
  • COX-deficient mouse models offer a powerful tool to dissect isoform-specific functions.

Purpose of the Study:

  • To summarize the phenotypes of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) knockout mice.
  • To discuss the impact of COX deficiency on cancer, inflammation, gastric ulceration, and reproduction.
  • To explore the utility of mice deficient in both COX isoforms or with single-copy genes.

Main Methods:

  • Review and summarization of existing research on COX-deficient mouse models.
  • Phenotypic analysis of Ptgs (genes coding for COX-1 and COX-2) knockouts.
  • Comparison of genetic ablation of COX activity with pharmacological inhibition using NSAIDs.

Main Results:

  • Prostaglandins derived from COX-1 and COX-2 exhibit both distinct and overlapping physiological functions.
  • COX-2 deficiency demonstrates more substantial effects on maintaining normal physiology compared to COX-1 deficiency.
  • COX-deficient models provide insights into inflammation, cancer, gastric health, and reproductive processes.

Conclusions:

  • COX-2 plays a more critical role in maintaining physiological homeostasis than COX-1.
  • COX-deficient mouse models are valuable for studying prostaglandin roles and comparing genetic versus pharmacological inhibition.
  • Further research into isoform-specific functions can guide the development of targeted anti-inflammatory and anti-cancer therapies.